Tardive dyskinesia: Deterioration of symptoms · chronic schizophrenia patients with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Mental state · chronic schizophrenia patients with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Adverse effects · chronic schizophrenia patients with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Leaving the study early · chronic schizophrenia patients with antipsychotic‐induced tardive dyskinesia
It is very uncertain whether withdrawal of anticholinergic medication changes acceptability of the treatment: leaving the study early compared with continuing anticholinergic medication (very low certainty).
1 finding from 1 review
Social confidence, social inclusion, social networks, or personalised quality of life · chronic schizophrenia patients with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Death (any cause) (median · hospitalised adult patients
Medication review showed no clear difference in mortality (all‐cause) Median compared with standard care (low certainty).
1 finding from 1 review
Hospital readmission · hospitalised adult patients
Medication review probably leads to lower hospital readmission (all‐cause) Median compared with standard care (moderate certainty).
1 finding from 1 review
ED visits · hospitalised adult patients
Medication review showed no clear difference in hospital emergency department contacts (all‐cause) Median compared with standard care (low certainty).
1 finding from 1 review
Health‐related quality of lifeg Median · hospitalised adult patients
It is very uncertain whether medication review changes health‐related quality of lifeg Median compared with standard care (very low certainty).
1 finding from 1 review
Patient outcomes Lipid levels, HbA1C level, HIV viral load, number of major atherosclerosis disease events · any physician, and any patient treated for chronic diseases with long‐term medication use
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Health resource use Rate of hospitalisations, rate of emergency department encounters, rate of outpatient encounters, rate of oral steroid use · any physician, and any patient treated for chronic diseases with long‐term medication use
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Adverse events · any physician, and any patient treated for chronic diseases with long‐term medication use
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · People aged 12 years and over with painful TMD lasting 3 months or longer
1 finding from 1 review
Severity of depression at the end of treatment · clinical diagnosis of depression
1 finding from 1 review
Adverse events ( · clinical diagnosis of depression
1 finding from 1 review
Physical quality of life · clinical diagnosis of depression
1 finding from 1 review
Quality of life (emotional) · clinical diagnosis of depression
1 finding from 1 review
Average volume of total multiple fibroids (cm3) · women with uterine fibroids
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Uterine size (cm3) ‐ · women with uterine fibroids
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Change in fibroid related symptoms · women with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found